Related Experiment Video
Updated: Sep 2, 2025

Increasing Pulmonary Artery Pulsatile Flow Improves Hypoxic Pulmonary Hypertension in Piglets
Published on: May 11, 2015
A curious case of pulmonary hypertension in a child
A Shaheer Ahmed1, Gaurav Kumar Divani2, Shivank Gupta2
1Department of Cardiology, Vardhman Mahavir Medical College and Safdarjung Hospital, 7th floor, Super speciality block, New Delhi, 110029, India. ahmedshaheer53@gmail.com.
Insights
Constrictive pericarditis can cause severe pulmonary hypertension in children, mimicking idiopathic pulmonary hypertension. Early diagnosis and treatment of reversible causes like constrictive pericarditis are crucial for better outcomes.
Area of Science:
- Pediatric Cardiology
- Pulmonary Hypertension
- Cardiothoracic Surgery
Background:
- Pulmonary hypertension in children has diverse causes, some reversible.
- Idiopathic pulmonary hypertension is a diagnosis of exclusion.
- Prompt identification of treatable etiologies is essential.
Purpose of the Study:
- To report a rare case of pulmonary hypertension secondary to constrictive pericarditis in a child.
- To highlight the importance of considering reversible causes of pulmonary hypertension.
Main Methods:
- A 12-year-old boy with exertional dyspnea and fatigue was re-evaluated for presumed primary pulmonary hypertension.
- Diagnostic workup included a detailed clinical assessment and investigations leading to constrictive pericarditis diagnosis.
- The patient was referred for surgical management (pericardiectomy).
Main Results:
- Constrictive pericarditis was identified as the cause of severe pulmonary hypertension.
- The patient's symptoms were initially misattributed to idiopathic pulmonary hypertension.
- The diagnosis was confirmed, and surgical intervention was planned.
Conclusions:
- Constrictive pericarditis can present with severe pulmonary hypertension without typical congestive heart failure symptoms.
- This case underscores the need to exclude reversible causes before diagnosing idiopathic pulmonary hypertension.
- Thorough evaluation is critical for accurate diagnosis and management of pediatric pulmonary hypertension.
Background:
Pulmonary hypertension in young children can be due to a myriad of conditions. Few aetiologies of pulmonary hypertension are potentially reversible. An extensive workup for the cause of pulmonary hypertension is a must before attributing it to idiopathic pulmonary hypertension. We describe an uncommon aetiology of pulmonary hypertension in a young boy.
Case Presentation:
A 12-year-old child, with past history of tubercular pleural effusion, presented with dyspnoea on exertion and easy fatiguability for 2 years. He was evaluated elsewhere and was being treated as primary pulmonary hypertension with pulmonary vasodilators. The child was revaluated since the clinical features were not completely favouring the diagnosis. On detailed evaluation, a diagnosis of constrictive pericarditis was made. He was referred for pericardiectomy.
Conclusions:
Constrictive pericarditis presenting with severe pulmonary hypertension without congestive symptoms is very rare. In patients presenting with pulmonary hypertension, always look for a reversible cause before labeling them as idiopathic PAH.
More Related Videos
08:34Left Atrial Stenosis Induced Pulmonary Venous Arterialization and Group 2 Pulmonary Hypertension in Rat
Published on: November 18, 2018
09:23Shunt Surgery, Right Heart Catheterization, and Vascular Morphometry in a Rat Model for Flow-induced Pulmonary Arterial Hypertension
Published on: February 11, 2017
Related Concept Videos
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Pulmonary Embolism I: Introduction
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Pulmonary Cycle: Exhalation